Statistics
Publications
61
Citations
6K
H-Index
38
Active since
1983
Thomas Baumruker is an author at Novartis (Austria) specializing in life sciences, immunology, and signal transduction.
Publications per year
1983–2015
61
61
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text
Medicine, Immunology, Pharmacology +17
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Barbara Zemann, Bernd Kinzel, Mathias Müller et al. · Blood · 2005 · 262 citations · Full text
Richard A. Sturm, Thomas Baumruker, B. Robert Franza et al. · Genes & Development · 1987 · 244 citations · Full text
Watchara Kasinrerk, Edda Fiebiger, Irena Štefanová et al. · The Journal of Immunology · 1992 · 241 citations
1–5 of 61